HALOZYME THERAPEUTICS INC shareholders Q4 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 6 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

HALOZYME THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
TEALWOOD ASSET MANAGEMENT INC 44,623$1,6490.79%
FCF Advisors LLC 20,773$767,7700.22%
EXCHANGE TRADED CONCEPTS, LLC 14,129$522,2080.01%
MASSMUTUAL TRUST CO FSB/ADV 833$30,7880.00%
M&R CAPITAL MANAGEMENT INC 32$1,1830.00%
Versant Capital Management, Inc 21$7760.00%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q4 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.